Mark T Dransfield MD

Pulmonology•Birmingham, AL

Critical Care Medicine

Professor, Medicine, University of Alabama School of Medicine

Join to View Full Profile

2000 6th Ave SBirmingham, AL 35233
Phone+1 205-934-9999
Fax+1 205-975-5666

Summary

Medical Director, UAB Lung Health Center

Education & Training

University of Alabama Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003
University of Alabama Medical CenterResidency, Internal Medicine, 1997 - 2000
University of North Carolina at Chapel Hill School of MedicineClass of 1997

Certifications & Licensure

AL State Medical License 1998 - 2025
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study Start of enrollment: 2007 Feb 01
Completed
Phase 2
Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study Start of enrollment: 2008 Feb 01
Completed
Phase 2
Long-term Oxygen Treatment Trial Start of enrollment: 2009 Jan 01
Completed
Phase 3
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema Start of enrollment: 2009 Mar 01
Terminated
Phase 2
Simvastatin Therapy for Moderate and Severe COPD Start of enrollment: 2010 Mar 01
Terminated
Phase 3
Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA) Start of enrollment: 2010 Nov 01
Completed
Phase 2
Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD) Start of enrollment: 2012 Apr 01
Completed
Phase 4
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study Start of enrollment: 2012 Oct 01
Terminated
Not Applicable
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study) Start of enrollment: 2013 Jul 01
Completed
Not Applicable
Study of COPD Subgroups and Biomarkers
ACTIVE_NOT_RECRUITING
TOPIC Trial for COPD Start of enrollment: 2015 May 01
Completed
Early Phase 1
Evaluation of COPD Co-Pilot Start of enrollment: 2016 Oct 01
Unknown status
The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor Start of enrollment: 2017 Mar 16
COMPLETED
PHASE2
Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency Start of enrollment: 2019 Apr 08
COMPLETED
PHASE2
The Multicenter Topic Trial Start of enrollment: 2021 Dec 01
Withdrawn
Phase 2
COVID-19 Study of Safety and Tolerability of Alvelestat Start of enrollment: 2021 Jan 25
Completed
Phase 1, Phase 2
An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI Start of enrollment: 2020 Jun 28
COMPLETED
SPIROMICS Study of Early COPD Progression (SOURCE) Start of enrollment: 2021 Sep 08
RECRUITING
Join now to see all

Publications & Presentations

PubMed

Neutrophil-to-Lymphocyte Ratio as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS Cohort.
Daniel T Hoesterey, Hong Dang, Daniela Markovic, Russell G Buhr, Donald P Tashkin
Annals of the American Thoracic Society. 2025-12-01
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Chronic Obstructive Pulmonary Disease and Asthma: Insights From ADAPTABLE.
Christopher L Mosher, Amanda Stebbins, Courtney E Lamberton, Lisa M Wruck, Adrian F Hernandez
Journal of the American Heart Association. 2025-11-26
The impact of age on prevalence of anxiety, depression and stress in patients with chronic obstructive pulmonary disease.
Abebaw Mengistu Yohannes, Mark T Dransfield, Richard Casaburi, Nicola A Hanania
Journal of Psychosomatic Research. 2025-11-24

Journal Articles

Association of Dysanapsis with Chronic Obstructive Pulmonary Disease Among Older Adults
Alain Bertoni, Gerard Criner, Mark T Dransfield, Meilan K Han, Nadia N Hansel, Erin D Michos, Elizabeth C Oelsner, Karol E Watson, JAMA

Authored Content

Association of Dysanapsis with Chronic Obstructive Pulmonary Disease Among Older AdultsJune 2020

Press Mentions

Warriner Named 2025 Brewer-Heslin Award WinnerAugust 19th, 2025
Ananda and Rita Basu Celebrated at Spring 2025 Endowed Chairs and Professorships ReceptionMay 14th, 2025
Another Biologic Reduces COPD ExacerbationsApril 30th, 2025
Join now to see all